Table 2 |
|
|
Significance of positive ANA test in CTD and some non-autoimmune conditions [36] |
|
|
Useful for diagnosis |
Useful for monitoring or prognosis |
|
|
|
|
1) Lupus erythmatosus (LE) |
1) Juvenile chronic oligoarticular arthritis |
|
SLE |
2) Raynaud phenomenon |
|
|
|
|
Discoid LE |
Not useful for diagnosis |
|
|
|
|
Subacute cutaneous LE |
|
|
Neonatal LE |
1) Relatives of patients with CTD |
|
Overlap of two or more LE subsets |
2) Other autoimmune diseases (e.g., Rheumatoid arthritis, Idiopathic thrombocytopenia purpura, primary biliary cirrhosis, autoimmune thyroiditis) |
|
Overlap of LE with other CTD |
3) Drugs (e.g., procainamide, hydralazine) |
|
2) SS |
4) Silicone breast implant patients |
|
Cutaneous SS (morphea) |
5) Fibromyalgia |
|
Systemic SS |
6) Chronic infections |
|
a) Limited disease |
7) Neoplasms |
|
b) Diffuse disease |
8) Elderly persons |
|
3) PM/Dermatomyositis |
9) Pregnant women |
|
4) Sjögren's syndrome (primary and secondary) |
10) Healthy persons |
|
5) Mixed CTD |
|
|
6) Overlap and undifferentiated CTD |
|
|
|
|
|
Kumar et al. Diagnostic Pathology 2009 4:1 doi:10.1186/1746-1596-4-1 |
|